OpenAI Foundation pledges $100m to boost hepatitis C cure ra...
The OpenAI Foundation has committed $100m to help fund a new public health initiative initially focused on hepatitis C.
Newsletters and Deep Dive digital magazine
The OpenAI Foundation has committed $100m to help fund a new public health initiative initially focused on hepatitis C.
In a first for consumer wearables, Google has introduced a feature on Pixel Watch and Fitbit Air devices that it says can monitor insulin resistance.
pharmaphorum spoke with Alexander Seyf, CEO of Autolomous, about the future of AI in Australian biotech.
Consumer device giants are surging into the healthcare arena to make devices cheaper, more compact, and easier for patients to use.
Norwegian healthtech companies are operating inside NHS trusts – tackling everyday problems that shape care.
Editor's Picks
Newsletters and Deep Dive
digital magazine